美罗华
医学
淋巴瘤
嵌合抗原受体
蒽环类
内科学
弥漫性大B细胞淋巴瘤
心肌病
肿瘤科
免疫疗法
心力衰竭
癌症
乳腺癌
作者
Anthony Kanelidis,J. Raikhelkar,Gene Kim,Gabriel Sayer,Michael R. Bishop,Tamar S. Polonsky,Nir Uriel
标识
DOI:10.1016/j.jaccao.2020.06.005
摘要
A 66-year-old woman with advanced diffuse large B-cell lymphoma (DLBCL) was referred for chimeric antigen receptor (CAR) T cell therapy. She was diagnosed with DLBCL 6 years prior to presentation and had no significant past medical history. She received a total of 10 cycles of rituximab,
科研通智能强力驱动
Strongly Powered by AbleSci AI